Amphastar Pharmaceuticals, Inc. financial data

Symbol
AMPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
11570 Sixth Street, Rancho Cucamonga, CA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 292 % +34.5%
Quick Ratio 72 % +42.7%
Return On Equity 22.4 % -3.32%
Return On Assets 10.3 % -2.37%
Operating Margin 28.1 % -8.21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.7M shares -2.56%
Common Stock, Shares, Outstanding 47.6M shares -0.94%
Entity Public Float 1.2B USD -19.5%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 48.4M shares +0.34%
Weighted Average Number of Shares Outstanding, Diluted 52.1M shares -1.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 732M USD +13.6%
Cost of Revenue 358M USD +22.1%
Research and Development Expense 73.9M USD +0.24%
Selling and Marketing Expense 37.8M USD +31%
General and Administrative Expense 56.7M USD +10.1%
Operating Income (Loss) 205M USD +4.28%
Nonoperating Income (Expense) -15.7M USD +38.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 190M USD +10.7%
Income Tax Expense (Benefit) 29.7M USD -6.79%
Net Income (Loss) Attributable to Parent 160M USD +16%
Earnings Per Share, Basic 3.29 USD/shares +15.4%
Earnings Per Share, Diluted 3.06 USD/shares +17.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 152M USD +5.07%
Accounts Receivable, after Allowance for Credit Loss, Current 136M USD +18.6%
Inventory, Net 154M USD +45.3%
Assets, Current 534M USD +9.08%
Deferred Income Tax Assets, Net 71.1M USD +33.6%
Property, Plant and Equipment, Net 297M USD +5.16%
Operating Lease, Right-of-Use Asset 46.9M USD +45.1%
Goodwill 3.05M USD -5.19%
Other Assets, Noncurrent 26M USD +0.32%
Assets 1.58B USD +4.27%
Accounts Payable, Current 30.5M USD +20%
Employee-related Liabilities, Current 26M USD +3.2%
Accrued Liabilities, Current 127M USD +86.3%
Liabilities, Current 174M USD -22.9%
Long-term Debt and Lease Obligation 602M USD +2.04%
Accrued Income Taxes, Noncurrent 6.96M USD +14.7%
Deferred Income Tax Liabilities, Net 201K USD -16.9%
Operating Lease, Liability, Noncurrent 41.9M USD +40.9%
Other Liabilities, Noncurrent 20.9M USD -7.8%
Liabilities 845M USD -3.24%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9.18M USD -8.29%
Retained Earnings (Accumulated Deficit) 569M USD +39%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 732M USD +14.5%
Liabilities and Equity 1.58B USD +4.27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 55.3M USD +36.9%
Net Cash Provided by (Used in) Financing Activities -13.6M USD -0.23%
Net Cash Provided by (Used in) Investing Activities 15.2M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 60.8M shares +2.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 56.9M USD +177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 152M USD +5.06%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.63M USD +593%
Deferred Tax Assets, Valuation Allowance 22.4M USD +9.27%
Deferred Tax Assets, Gross 140M USD +25.7%
Operating Lease, Liability 48.7M USD +44.8%
Depreciation 6.82M USD +9.02%
Payments to Acquire Property, Plant, and Equipment 8.79M USD -7.22%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 159M USD +15.3%
Lessee, Operating Lease, Liability, to be Paid 59.3M USD +42.9%
Property, Plant and Equipment, Gross 569M USD +7.74%
Operating Lease, Liability, Current 6.8M USD +74.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.4M USD +69.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.58M USD +70.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +18.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.6M USD +35%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.22M USD +65%
Deferred Tax Assets, Operating Loss Carryforwards 22M USD +9.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 13.7M USD +9.97%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.48M USD +58.3%
Additional Paid in Capital 505M USD +3.98%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.17M USD +2459%
Depreciation, Depletion and Amortization 38.8M USD +98.7%
Share-based Payment Arrangement, Expense 24.4M USD +20.4%
Interest Expense 35.4M USD +1772%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%